{"id":"placebo-oral-liquid","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo expectation)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance with no active pharmaceutical ingredients. Its therapeutic effects, when observed, arise from patient expectation, conditioning, and psychological mechanisms rather than direct molecular action. It is commonly used as a control in clinical trials to distinguish true drug efficacy from placebo response.","oneSentence":"Placebo produces no pharmacological effect and works through psychological expectation and the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:42:08.021Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical trial control/comparator (not a therapeutic indication)"}]},"trialDetails":[{"nctId":"NCT07282483","phase":"PHASE2","title":"Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-16","conditions":"Radiation-induced Oral Mucositis","enrollment":118},{"nctId":"NCT05556824","phase":"PHASE2","title":"Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Microbiome Health Sciences","startDate":"2023-03-03","conditions":"Gastroesophageal Reflux","enrollment":247},{"nctId":"NCT07339774","phase":"PHASE2","title":"Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2026-03-30","conditions":"Radiotherapy-induced Oral Mucositis","enrollment":128},{"nctId":"NCT07264192","phase":"PHASE1","title":"A Study of HS-10518 in Healthy Adult Premenopausal Females in China","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2025-03-11","conditions":"Infertility, Female","enrollment":60},{"nctId":"NCT06423235","phase":"PHASE4","title":"Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules","status":"RECRUITING","sponsor":"Xintian Pharmaceutical","startDate":"2024-07-30","conditions":"Thyroid Nodule","enrollment":234},{"nctId":"NCT05452564","phase":"PHASE2","title":"Baricitinib for Reduction of HIV - CNS","status":"RECRUITING","sponsor":"William Tyor","startDate":"2023-05-18","conditions":"Human Immunodeficiency Virus","enrollment":95},{"nctId":"NCT05037487","phase":"PHASE1","title":"Evaluation of Smoked THC and CBD in Men and Women","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-09-01","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":19},{"nctId":"NCT07479290","phase":"PHASE1","title":"Effect of Local Use of Vitamin D on the Rate of Canine Distillization: a Split Mouth Randomized Control Trial","status":"RECRUITING","sponsor":"Foundation University Islamabad","startDate":"2026-02-20","conditions":"Malocclusion of Anterior Teeth","enrollment":30},{"nctId":"NCT05983588","phase":"PHASE2","title":"PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Technical University of Munich","startDate":"2023-12-12","conditions":"Corticobasal Syndrome (CBS)","enrollment":32},{"nctId":"NCT07478744","phase":"PHASE2","title":"A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder","status":"NOT_YET_RECRUITING","sponsor":"Synendos Therapeutics AG","startDate":"2026-04","conditions":"Generalized Anxiety Disorder","enrollment":24},{"nctId":"NCT07463495","phase":"NA","title":"The Metabolic Effects of Oral Tributyrin Administration","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2026-02-20","conditions":"Healthy Overweight/Obese","enrollment":12},{"nctId":"NCT01631617","phase":"PHASE2","title":"Effects of Treatments on Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2012-09-18","conditions":"Eczema, Dermatitis, Skin Diseases, Genetic","enrollment":130},{"nctId":"NCT06807268","phase":"PHASE3","title":"A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema","status":"RECRUITING","sponsor":"Pfizer","startDate":"2025-07-24","conditions":"Eczema","enrollment":150},{"nctId":"NCT04004117","phase":"PHASE2, PHASE3","title":"Effect of Sublingual Fentanyl on Breathlessness in COPD","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2019-07-01","conditions":"Copd","enrollment":40},{"nctId":"NCT07448974","phase":"PHASE3","title":"Vitamin D and Type 2 Diabetes - Treat-To-Target","status":"NOT_YET_RECRUITING","sponsor":"Tufts Medical Center","startDate":"2026-05","conditions":"Prediabetes, Type 2 Diabetes (T2DM)","enrollment":100},{"nctId":"NCT04302870","phase":"PHASE2, PHASE3","title":"Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-02-27","conditions":"Motor Neuron Disease, Amyotrophic Lateral Sclerosis","enrollment":1150},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT06333041","phase":"PHASE2, PHASE3","title":"Study of Cannabidiol in Sanfilippo Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2026-03-15","conditions":"Sanfilippo Syndrome, Mucopolysaccharidosis III","enrollment":35},{"nctId":"NCT07224581","phase":"PHASE3","title":"Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder","status":"RECRUITING","sponsor":"GRIN Therapeutics, Inc.","startDate":"2026-01-05","conditions":"GRIN-related Neurodevelopmental Disorder","enrollment":100},{"nctId":"NCT05067387","phase":"PHASE1","title":"Evaluation of Oral THC and CBD in Men and Women","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-04-15","conditions":"Drug Abuse, Intoxication by Drug, Impairment","enrollment":22},{"nctId":"NCT07430670","phase":"NA","title":"Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery","status":"RECRUITING","sponsor":"Universidad Complutense de Madrid","startDate":"2026-02-17","conditions":"Gingival Recession, Localized","enrollment":30},{"nctId":"NCT02148796","phase":"PHASE2","title":"Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2017-01-01","conditions":"Asthma, Wheezing","enrollment":822},{"nctId":"NCT05726396","phase":"PHASE2","title":"A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2025-09-23","conditions":"Immune-related Colitis, Colitis","enrollment":""},{"nctId":"NCT06300398","phase":"PHASE1","title":"IAMA-6 Oral Dose Study in Healthy Adults","status":"COMPLETED","sponsor":"Iama Therapeutics S.r.l.","startDate":"2024-01-08","conditions":"Neurodevelopmental Disorders","enrollment":72},{"nctId":"NCT07146451","phase":"","title":"6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-28","conditions":"Children Born to Mothers Enrolled in the TOCOPROM Trial","enrollment":480},{"nctId":"NCT05712200","phase":"PHASE3","title":"Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)","status":"RECRUITING","sponsor":"Anthos Therapeutics, Inc.","startDate":"2022-12-27","conditions":"Atrial Fibrillation (AF)","enrollment":1900},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT06980636","phase":"PHASE4","title":"A Trial of Shengmai Liquid for Long COVID Fatigue.","status":"RECRUITING","sponsor":"Beijing University of Chinese Medicine","startDate":"2025-12-01","conditions":"Long COVID Fatigue","enrollment":100},{"nctId":"NCT07397026","phase":"PHASE1","title":"Clinical and Laboratory Evaluation of Resveratrol Loaded Nanoparticles in the Treatment of Periodontitis: A Randomized Controlled Clinical Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hagar Ahmed Ali Mohammed Elzain","startDate":"2025-08-09","conditions":"Periodontitis Stage III","enrollment":48},{"nctId":"NCT07392931","phase":"NA","title":"Safety and Efficacy of Racecadotril in Children With Acute Watery Diarrhea","status":"COMPLETED","sponsor":"Punjab Rangers Teaching Hospital Lahore","startDate":"2025-06-01","conditions":"Acute Watery Diarrhea","enrollment":200},{"nctId":"NCT07391267","phase":"NA","title":"Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2026-02-01","conditions":"Chronic Kidney Diseases, MAFLD","enrollment":90},{"nctId":"NCT07380230","phase":"NA","title":"Efficacy and Safety of Qibei Jiedu Formula for Preventing and Managing Acute Radiation Dermatitis in Breast Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"LI FENG","startDate":"2026-01-27","conditions":"Acute Radiation Dermatitis, Traditional Chinese Medicine (TCM), Breast Cancer","enrollment":60},{"nctId":"NCT06629324","phase":"PHASE2","title":"Evaluating Bone Marrow Cell Transplant for Treating Cerebral Palsy From Brain Hypoxia","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2024-10-15","conditions":"Autism Spectrum Disorder","enrollment":58},{"nctId":"NCT06853223","phase":"PHASE2","title":"This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-12-07","conditions":"Primary Graft Dysfunction, Lung Transplantation, Acute Lung Injury(ALI)","enrollment":120},{"nctId":"NCT04411225","phase":"PHASE3","title":"Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2022-06-01","conditions":"Early Psychosis","enrollment":120},{"nctId":"NCT07005180","phase":"PHASE2","title":"Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Hillhurst Biopharmaceuticals, Inc.","startDate":"2026-02-28","conditions":"Parkinson Disease","enrollment":36},{"nctId":"NCT05248191","phase":"PHASE1","title":"FMT for Postop Crohn's Disease","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2022-04-20","conditions":"Crohn Disease","enrollment":23},{"nctId":"NCT07282145","phase":"PHASE1","title":"Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers","status":"RECRUITING","sponsor":"Bichedam Co., Ltd.","startDate":"2025-09-11","conditions":"Essential Hypertension","enrollment":56},{"nctId":"NCT02408354","phase":"PHASE2","title":"Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2015-03-25","conditions":"Alternating Hemiplegia of Childhood","enrollment":10},{"nctId":"NCT04128969","phase":"PHASE2","title":"Causal Mechanisms in Adolescent Arterial Stiffness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2020-02-01","conditions":"Lipid Disorder, Dyslipidemias, Aortic Stiffness","enrollment":90},{"nctId":"NCT06590090","phase":"PHASE2","title":"Natrunix in Combination With Methotrexate for Rheumatoid Arthritis Treatment","status":"NOT_YET_RECRUITING","sponsor":"XBiotech, Inc.","startDate":"2026-07-15","conditions":"Rheumatoid Arthritis","enrollment":108},{"nctId":"NCT07266324","phase":"PHASE2","title":"A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.","status":"NOT_YET_RECRUITING","sponsor":"Bright Minds Biosciences Pty Ltd","startDate":"2026-01","conditions":"Prader-Willi Syndrome","enrollment":16},{"nctId":"NCT07254988","phase":"NA","title":"Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders","status":"RECRUITING","sponsor":"University of Copenhagen","startDate":"2023-03-24","conditions":"Spinal Muscular Atrophy (SMA), Cerebral Palsy (CP), Duchenne Muscular Dystrophy (DMD)","enrollment":8},{"nctId":"NCT05809908","phase":"PHASE3","title":"Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study","status":"NOT_YET_RECRUITING","sponsor":"Cerecin","startDate":"2026-06","conditions":"Alzheimer Disease","enrollment":535},{"nctId":"NCT07221370","phase":"PHASE2, PHASE3","title":"Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients","status":"RECRUITING","sponsor":"Riverside University Health System Medical Center","startDate":"2024-10-21","conditions":"Clostridium Difficile Infection, Vancomycin Resistant Enterococci Infection","enrollment":176},{"nctId":"NCT06562114","phase":"PHASE1","title":"A Phase 1 Safety and Tolerability Study of TML-6 in Healthy and Elderly Volunteers for Alzheimer's Disease Treatment","status":"COMPLETED","sponsor":"Merry Life Biomedical Co., Ltd.","startDate":"2024-07-11","conditions":"Healthy","enrollment":72},{"nctId":"NCT04718389","phase":"PHASE3","title":"A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2021-01-26","conditions":"Asthma","enrollment":1719},{"nctId":"NCT05444959","phase":"PHASE2, PHASE3","title":"The Impact of Exercise / Stress Stimuli on HMB Supplementation Efficacy","status":"COMPLETED","sponsor":"Poznan University of Physical Education","startDate":"2021-09-10","conditions":"Supplementation, Sport, Sports Nutrition","enrollment":130},{"nctId":"NCT07198243","phase":"PHASE4","title":"The Effects of STW 5-II on Duodenal Mucosa and Symptoms in Functional Dyspepsia","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2025-09-30","conditions":"Functional Dyspepsia","enrollment":100},{"nctId":"NCT07098663","phase":"PHASE2","title":"Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes","status":"RECRUITING","sponsor":"Mankind Pharma Limited","startDate":"2025-08-12","conditions":"Type 2 Diabetes Mellitus (T2DM), Food Effect, Safety and Tolerability","enrollment":68},{"nctId":"NCT07194629","phase":"PHASE4","title":"Pilot and Feasibility Study of Impact of SDF 38% Application on Oral Health of Elderly With Autonomy Loss","status":"NOT_YET_RECRUITING","sponsor":"Université de Montréal","startDate":"2025-10-01","conditions":"Dental Caries, Elderly, Loss of Autonomy","enrollment":60},{"nctId":"NCT07191912","phase":"PHASE3","title":"Confirmatory Study of Govorestat in CMT-SORD","status":"NOT_YET_RECRUITING","sponsor":"Applied Therapeutics, Inc.","startDate":"2025-10","conditions":"Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (CMT-SORD)","enrollment":155},{"nctId":"NCT07177066","phase":"PHASE1","title":"A Study of EDG-15400 in Healthy Adults","status":"RECRUITING","sponsor":"Edgewise Therapeutics, Inc.","startDate":"2025-08-20","conditions":"Healthy Adults","enrollment":108},{"nctId":"NCT05397665","phase":"PHASE2, PHASE3","title":"Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"Applied Therapeutics, Inc.","startDate":"2022-01-01","conditions":"Hereditary Neuropathy Caused by SORD Deficiency","enrollment":56},{"nctId":"NCT03785158","phase":"NA","title":"MIND After Surgery","status":"COMPLETED","sponsor":"McMaster University","startDate":"2021-09-14","conditions":"Post-operative Delirium, Major Non-cardiac Surgery","enrollment":88},{"nctId":"NCT06556056","phase":"NA","title":"An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)","status":"COMPLETED","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2024-06-30","conditions":"Androgenic Alopecia","enrollment":108},{"nctId":"NCT07157748","phase":"NA","title":"Effects of Compound Ejiao Syrup on Exercise Tolerance and Quality of Life in Critically Ill Patients After ICU Discharge: A Double-Blind, Multicenter,Randomized Controlled Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Third Military Medical University","startDate":"2025-12","conditions":"Critically Ill Patients","enrollment":178},{"nctId":"NCT02919631","phase":"PHASE2","title":"Triheptanoin in Mc Ardle","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2016-11-16","conditions":"Glycogen Storage Disease Type V","enrollment":12},{"nctId":"NCT06984484","phase":"NA","title":"Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease","status":"RECRUITING","sponsor":"Devintec Sagl","startDate":"2025-07-02","conditions":"Gastroesophageal Reflux Disease (GERD)","enrollment":208},{"nctId":"NCT06675500","phase":"PHASE3","title":"Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-11-01","conditions":"Atrial Fibrillation (AF), Magnesium Sulfate, Post Cardiac Surgery Patients","enrollment":130},{"nctId":"NCT06450925","phase":"PHASE2","title":"Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2025-03-25","conditions":"Graft Vs Host Disease, Vitamin A Deficiency, Vitamin D Deficiency","enrollment":190},{"nctId":"NCT04659278","phase":"NA","title":"Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use","status":"WITHDRAWN","sponsor":"Endourage, LLC","startDate":"2025-09","conditions":"Alcohol Drinking, Alcohol Use, Unspecified, Alcohol Abstinence","enrollment":""},{"nctId":"NCT03787628","phase":"PHASE2","title":"Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2022-05-19","conditions":"Opioid-use Disorder","enrollment":35},{"nctId":"NCT04482244","phase":"PHASE2","title":"RCT of CBD for Anxiety in Advanced Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2022-01-19","conditions":"Advanced Breast Cancer, Anxiety, CBD","enrollment":60},{"nctId":"NCT04046900","phase":"PHASE1, PHASE2","title":"Vaginal Microbiota Transplant","status":"RECRUITING","sponsor":"Douglas Kwon","startDate":"2021-04-22","conditions":"Recurrent Bacterial Vaginosis","enrollment":62},{"nctId":"NCT01825798","phase":"PHASE3","title":"Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2013-04","conditions":"Overweight, Autism Spectrum Disorder","enrollment":60},{"nctId":"NCT05324982","phase":"PHASE1","title":"Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-08-09","conditions":"Behavioral Pharmacology of Cannabis","enrollment":30},{"nctId":"NCT04870333","phase":"PHASE2, PHASE3","title":"PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2021-02-19","conditions":"Covid19","enrollment":2240},{"nctId":"NCT04129931","phase":"PHASE2","title":"PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2019-12-19","conditions":"Asthma","enrollment":395},{"nctId":"NCT06082843","phase":"PHASE2","title":"A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2024-01-03","conditions":"Hypertension, Portal, Liver Cirrhosis","enrollment":22},{"nctId":"NCT04992065","phase":"PHASE2","title":"A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-08-03","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":267},{"nctId":"NCT04721691","phase":"PHASE1","title":"Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2021-03-10","conditions":"Electrical Status Epilepticus of Slow-Wave Sleep","enrollment":16},{"nctId":"NCT04645927","phase":"NA","title":"Clinical Trial to Study the Effects of Dietary Flax Beverage on Memory and Cognition","status":"COMPLETED","sponsor":"St. Boniface Hospital","startDate":"2020-10-09","conditions":"Memory; Disturbance, Mild","enrollment":19},{"nctId":"NCT06251050","phase":"PHASE1, PHASE2","title":"A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing Radiotherapy","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2024-03-01","conditions":"Head and Neck Squamous Cell Carcinoma, Malignant Head and Neck Tumors","enrollment":175},{"nctId":"NCT02839915","phase":"PHASE2","title":"Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Southwest Autism Research & Resource Center","startDate":"2020-08-13","conditions":"Autism Spectrum Disorder","enrollment":56},{"nctId":"NCT03835117","phase":"PHASE2","title":"Effect of a Wide Spectrum Nutritional Supplement on Mitochondrial Function in Children With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Rossignol Medical Center","startDate":"2020-02-01","conditions":"Autism Spectrum Disorder","enrollment":16},{"nctId":"NCT06126653","phase":"PHASE2","title":"A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Aardvark Therapeutics, Inc.","startDate":"2024-08-01","conditions":"Autism Spectrum Disorder","enrollment":5},{"nctId":"NCT02616484","phase":"PHASE3","title":"Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saol Therapeutics Inc","startDate":"2020-07-14","conditions":"Pyruvate Dehydrogenase Complex Deficiency","enrollment":34},{"nctId":"NCT06303128","phase":"PHASE3","title":"Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge","status":"RECRUITING","sponsor":"James Tarbox, MD","startDate":"2024-02-03","conditions":"Penicillin Allergy","enrollment":380},{"nctId":"NCT06953869","phase":"PHASE3","title":"Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia","status":"RECRUITING","sponsor":"Vanda Pharmaceuticals","startDate":"2025-04-21","conditions":"Insomnia Disorder","enrollment":420},{"nctId":"NCT04298203","phase":"PHASE2","title":"Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-04","conditions":"Obesity","enrollment":100},{"nctId":"NCT05028153","phase":"PHASE2","title":"Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms","status":"RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2022-11-14","conditions":"Childhood Asthma With Acute Exacerbation","enrollment":320},{"nctId":"NCT04679389","phase":"PHASE2, PHASE3","title":"Acetazolamide Efficacy in Ataxia in PMM2-CDG","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2021-03-17","conditions":"Pmm2-CDG, CDG1A","enrollment":25},{"nctId":"NCT03825965","phase":"PHASE3","title":"Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT","status":"COMPLETED","sponsor":"McMaster University","startDate":"2023-05-03","conditions":"Knee Osteoarthritis","enrollment":39},{"nctId":"NCT06731647","phase":"PHASE2","title":"Non-steroidal Anti-inflammatory Drugs in Pleurodesis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-02-01","conditions":"Non-steroidal Anti-inflammatory Drugs, Pleurodesis, Pneumothorax","enrollment":358},{"nctId":"NCT04008355","phase":"PHASE2","title":"A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP","status":"COMPLETED","sponsor":"AlzProtect SAS","startDate":"2020-06-22","conditions":"Progressive Supranuclear Palsy","enrollment":36},{"nctId":"NCT03257215","phase":"PHASE4","title":"Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study","status":"TERMINATED","sponsor":"Murdoch Childrens Research Institute","startDate":"2017-10-16","conditions":"Atopic Dermatitis","enrollment":13},{"nctId":"NCT06708702","phase":"PHASE2","title":"Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy","status":"RECRUITING","sponsor":"Instituto Nacional de Cancer, Brazil","startDate":"2025-01-17","conditions":"Oral Mucositis, Oral Mucositis (Ulcerative) Due to Radiation, Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy","enrollment":40},{"nctId":"NCT06166654","phase":"PHASE4","title":"Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload","status":"RECRUITING","sponsor":"Johannes Grand","startDate":"2024-09-05","conditions":"Acute Heart Failure","enrollment":939},{"nctId":"NCT05290493","phase":"PHASE2","title":"NB-001 in Children and Adolescents With 22q11 Deletion Syndrome","status":"COMPLETED","sponsor":"Nobias Therapeutics, Inc.","startDate":"2022-02-10","conditions":"22q11 Deletion Syndrome","enrollment":37},{"nctId":"NCT02802423","phase":"PHASE1, PHASE2","title":"Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.","status":"NOT_YET_RECRUITING","sponsor":"BioLite, Inc.","startDate":"2026-01-01","conditions":"Triple Negative Breast Cancer","enrollment":44},{"nctId":"NCT02933762","phase":"PHASE1","title":"A Study in Healthy Participants to Evaluate the Effect of JNJ-54175446 on Amyloid Biomarkers and Cytokine Profiles in Cerebrospinal Fluid and Plasma","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2016-09","conditions":"Healthy","enrollment":25},{"nctId":"NCT06801951","phase":"NA","title":"Oral Supplement and Acute Resistance Exercise","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2017-12-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":16},{"nctId":"NCT06218056","phase":"PHASE2","title":"Cannabidiol for Reducing Cigarette Use","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2024-10-31","conditions":"Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence","enrollment":120},{"nctId":"NCT05275855","phase":"PHASE1","title":"First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-04-29","conditions":"Healthy Volunteers","enrollment":110},{"nctId":"NCT04846036","phase":"PHASE2","title":"The KHENERGYC Study","status":"SUSPENDED","sponsor":"Khondrion BV","startDate":"2021-02-01","conditions":"Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation, MELAS","enrollment":24},{"nctId":"NCT05092841","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A","status":"COMPLETED","sponsor":"Tasly GeneNet Pharmaceuticals Co., Ltd","startDate":"2021-09-28","conditions":"Charcot-Marie-Tooth Type 1A","enrollment":176},{"nctId":"NCT06280079","phase":"NA","title":"Ultra-high-caloric, Fatty Diet in ALS","status":"RECRUITING","sponsor":"University of Ulm","startDate":"2024-06-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":392},{"nctId":"NCT06275464","phase":"PHASE1","title":"BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Biora Therapeutics, Inc.","startDate":"2024-01-11","conditions":"Healthy","enrollment":48},{"nctId":"NCT01565707","phase":"PHASE3","title":"A Study to Investigate How Effective and Safe Solifenacin Succinate Suspension is in Treating Children/Adolescents Aged 5 to Less Than 18 Years With Symptoms of Overactive Bladder (OAB) Compared to a Non-active Drug","status":"COMPLETED","sponsor":"Astellas Pharma Europe B.V.","startDate":"2012-06-07","conditions":"Urinary Bladder, Overactive","enrollment":189}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["hydrochloric acid"],"phase":"marketed","status":"active","brandName":"Placebo oral liquid","genericName":"Placebo oral liquid","companyName":"McGill University Health Centre/Research Institute of the McGill University Health Centre","companyId":"mcgill-university-health-centre-research-institute-of-the-mcgill-university-heal","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces no pharmacological effect and works through psychological expectation and the placebo effect. Used for Clinical trial control/comparator (not a therapeutic indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}